Internists
34 years of experience

University Area
Alaska Native Medical Center, Phs
4315 Diplomacy Dr
Anchorage, AK 99508
907-729-2078
Locations and availability (1)

Education ?

Medical School Score Rankings
Yale University (1976)
  • Currently 4 of 4 apples
Top 25%

Awards & Distinctions ?

Associations
American Board of Internal Medicine

Affiliations ?

Dr. Neubauer is affiliated with 2 hospitals.

Hospital Affilations

Score

Rankings

  • Providence Alaska Medical Center
    PO Box 196604, Anchorage, AK 99519
    • Currently 1 of 4 crosses
  • Alaska Native Medical Center, Phs
    4315 Diplomacy Dr, Anchorage, AK 99508
    • Currently 1 of 4 crosses
  • Publications & Research

    Dr. Neubauer has contributed to 11 publications.
    Title Pay-for-performance Principles That Promote Patient-centered Care: an Ethics Manifesto.
    Date December 2007
    Journal Annals of Internal Medicine
    Excerpt

    Pay-for-performance programs are growing, but little evidence exists on their effectiveness or on their potential unintended consequences and effects on the patient-physician relationship. Pay-for-performance has the potential to help improve the quality of care, if it can be aligned with the goals of medical professionalism. Initiatives that provide incentives for a few specific elements of a single disease or condition, however, may neglect the complexity of care for the whole patient, especially the elderly patient with multiple chronic conditions. Such programs could also result in the deselection of patients, "playing to the measures" rather than focusing on the patient as a whole, and misalignment of perceptions between physicians and patients. The primary focus of the quality movement in health care should not be on "pay for" or "performance" based on limited measures, but rather on the patient. The American College of Physicians hopes to move the pay-for-performance debate forward with a patient-centered focus--one that puts the needs and interests of the patient first--as these programs evolve.

    Title Paranoia over Privacy.
    Date August 2006
    Journal Annals of Internal Medicine
    Title Saving (internal) Medicine.
    Date May 2006
    Journal Annals of Internal Medicine
    Title "practice Makes Perfect"...or Does It?
    Date July 2005
    Journal Annals of Internal Medicine
    Title The 28th Amendment.
    Date September 1999
    Journal Annals of Internal Medicine
    Title Plasmapheresis: First Year of Experience at Humana Hospital-alaska.
    Date April 1991
    Journal Alaska Medicine
    Excerpt

    This report summarizes the first year of experience with therapeutic plasmapheresis at Human Hospital-Alaska. Eleven patients had plasmapheresis; 6 patients with the Guillain-Barré syndrome, and patients with thrombotic thrombocytopenic purpura (TTP), Eaton-Lambert syndrome, myasthenia gravis, post transfusion purpura, and multiple myeloma complicated by hyperviscosity and coagulopathy. Many of our patients appeared to benefit from plasmapheresis, but we also report a variety of complications. Our approach to establishing plasmapheresis in a community hospital setting is discussed.

    Title Renovascular Hypertension and Demyelimating Disease in a Young Woman.
    Date January 1990
    Journal Alaska Medicine
    Excerpt

    Renal artery stenosis is an uncommon, but curable cause of systemic hypertension. The most common causes of stenosis are atherosclerosis, and fibromuscular dysplasia. Diagnosis may be difficult due to the lack of a suitable screening test, and a high index of suspicion needs to be maintained. Treatment may be with pharmacotherapy, renal angioplasty, or surgery and the choice of therapy needs to be tailored to the individual patient. Once a stenotic lesion is discovered in a hypertensive patient, the functional significance is not always clear cut. Fibromuscular dysplasia may be a systemic disease in some cases, and may affect the central nervous system.

    Title Thrombotic Thrombocytopenic Purpura.
    Date August 1989
    Journal Alaska Medicine
    Excerpt

    This case represents a classical presentation of severe TTP. At the time of diagnosis, the patient had a markedly depressed platelet count and evidence of severe hemolytic enemia. Her neurologic symptoms were not ominous at the time of initial presentation but may have worsened rapidly without treatment. She also demonstrates the success of current treatment modalities. A combination of plasma infusion followed by plasmapheresis, anti-platelet agents, corticosteroids, and vincristine was employed. As in most cases of TTP reviewed in the medical literature, it is difficult to sort out which treatment modality was most responsible for the improvement. Since this is such a deadly disease, there is a tendency to treat with a combination of agents in addition to plasmapheresis. Nonetheless, an impression remains that plasmapheresis was most closely associated with her recovery. As an additional comment, the use of plasmapheresis in this patient represented the first use of a pheresis machine that had been obtained in Anchorage, Alaska at the urging of the medical community. Our location, remote from academic centers, has made the use of technology such as plasmapheresis less accessible. The presence of plasmapheresis capabilities in a community setting such as ours raises many questions pertaining to the appropriateness of use of the technology, management of complications, etc.. We plan to carefully monitor these parameters.

    Title Public Health Services Corps: a Second Opinion.
    Date January 1981
    Journal Group Practice Journal
    Excerpt

    Numerous issues concerning the value of the Public Health Service Corps experience were raised in a recent article, "Why I Am Leaving a Rural Practice," by Paul A. Johnson, M.D. Because responses to tht essay were particularly pertinent to the future of group practice in rural America, Group Practice sought to offer another viewpoint by asking Richard L. Neubauer, M.D., to describe his PHSC experience.

    Title Fractionation of Dna Nucleotide Transcripts from Moloney Sarcoma Virus and Isolation of Sarcoma Virus-specific Complementary Dna.
    Date August 1976
    Journal Journal of Virology
    Excerpt

    Radioactive DNA complementary to nucleotide sequences in Moloney murine sarcoma virus (MSV) and Moloney leukemia virus (M-MuLV) complex was made by the endogenous reverse transcriptase reaction. These virus stocks contained a threefold excess of MSV over M-MuLV as measured by biological assay. The complementary DNA was an accurate copy of the viral RNA in that 86% of 35S viral RNA hybridized with complementary (cDNA) DNA at a 1.5 to 1 cDNA-RNA molar ratio. The complementary DNA, of a 4-6S size, was fractionated by sequential absorptions with MulV and the feline leukemia virus pseudotype of MSV, [MSV(FeLV)] RNA. In this manner three sets of nucleotide sequences whichrepresent different portions of the MSV viral complex were obtained: a sarcoma virus-specific fraction (cDNAsarc) with sequences that had no homology to M-MuLV RNA but which hybridized to MSV (FeLV) RNA, a sarcoma-leukemia fraction (cDNA common) with sequences common to MSV as well as M-MuLV viral RNA, and a cDNAleuk representing those nucleotide sequences found only in M-MuLV. Hybridization of MSV-MuLV viral 35S RNA with a threefold molar excess of cDNA's revealed that approximately 20% was hybridized with cDNAsarc, whereas approximately 75% was hybridized with cDNAcommon. M-MuLV 35S RNA alone did not hybridize with cDNAsarc but did hybridize 40 and 50% with cDNAleuk and cDNAcommon, respectively. The cDNAsarc represents about 25% of the total MSV sequences, whereas the cDNAcommon represents the remainder of the MSV virus genome. Some cDNAcommon sequences were shared by two other sarcoma viruses and several distinctly different isolates of MulV. In contrast, the MSV "sarc" sequences had little or no homology with two other murine sarcoma virus isolates.

    Title Elimination of the Sarcoma Genome from Murine Sarcoma Virus Transformed Cat Cells.
    Date May 1976
    Journal Science (new York, N.y.)
    Excerpt

    Cat cells transformed by Moloney murine sarcoma virus contain virus-specific sequences in their RNA and DNA. Cloned, spontaneous revertant cell lines derived from clones of these cells had no evidence of the sarcoma genome in the cell RNA or DNA as judged by RNA-complementary DNA or DNA-complementary DNA hybridizations. ?This is apparently the first report of loss of a transforming genome in a revertant cell line.


    Similar doctors nearby

    Dr. Christopher Michaeles

    Internal Medicine
    13 years experience
    Anchorage, AK

    Dr. Peter Sapin

    Internal Medicine
    35 years experience
    Anchorage, AK

    Dr. Elizabeth Saltonstall

    Internal Medicine
    Anchorage, AK

    Dr. David Dexter

    Internal Medicine
    17 years experience
    Anchorage, AK

    Dr. David Sears

    Internal Medicine
    3 years experience
    Anchorage, AK

    Dr. Molly Southworth

    Internal Medicine
    32 years experience
    Anchorage, AK
    Search All Similar Doctors